Related Experiment Video
Updated: Jul 31, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
Estimating influenza A subtype ratios among critical care admissions in England
Hannah Sophie Wolmuth-Gordon1, Suzanne Elgohari1, Gavin Dabrera1
1Respiratory Viruses, Immunisations and Vaccine-Preventable Diseases, https://ror.org/00vbvha87UK Health Security Agency - Colindale, UK.
Abstract:
We analysed weekly influenza A intensive care unit (ICU) or high dependency unit (HDU) admissions reported by age group and subtype by NHS trusts in England through mandatory surveillance during the 2023-2024 influenza season. We investigated whether subtype reporting varied with patient age group, NHS trust type and region. We estimated the subtype ratio and explored whether this estimate varied among subsets of trusts grouped by the regularity of subtype reporting. Our aim was to explore factors relating to subtype reporting and investigate how these affect subtype ratio estimates. 112 NHS trusts reported data, with 86 trusts reporting influenza A cases and 28 trusts reporting subtyped influenza A cases. The proportion of subtype reporting trusts varied with region and trust type, but not patient age group. The estimated ratio of influenza A(H1N1)pdm09 to influenza A(H3N2) was 3.13 (95% CI: 2.17, 4.51), indicating that influenza A(H1N1)pdm09 was dominant; this was approximately similar across levels of regularity of trust subtype reporting. The accuracy of subtype ratio estimates depends on the availability of influenza A subtype information and data representativeness. We identified low levels of subtype reporting, which likely limits early recognition of new influenza strains and informing of the prescription of antivirals in influenza outbreaks.
More Related Videos
05:38Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017